High-density lipoprotein metabolism and progression of atherosclerosis: new insights from the HDL Atherosclerosis Treatment Study

被引:31
|
作者
Asztalos, BF [1 ]
机构
[1] Tufts Univ, Lipid Metab Lab, HNRCA, Boston, MA 02111 USA
关键词
high-density lipoprotein; high-density lipoprotein subspecies; atherosclerosis; anti-atherogenicity;
D O I
10.1097/01.hco.0000126979.41946.7e
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose of review The purpose of this review is to summarize the current understanding of the potentially antiatherogenic properties of high-density lipoprotein related to its different components. Recent findings Recent findings on the role of the different high-density lipoprotein subspecies in reverse cholesterol transport, inflammation, endothelial dysfunction, and low-density lipoprotein oxidation are covered. Special emphasis is put on the heterogeneity of high-density lipoprotein and functional changes related to specific high-density lipoprotein particles with the potential therapeutic alterations of high-density lipoprotein metabolism. Summary The diverse action of high-density lipoprotein observed could be explained by the heterogeneity of high-density lipoprotein particles with completely different composition and properties. The modification of specific high-density lipoprotein subpopulations to reach the maximum atheroprotective effects under various pathologic conditions bears great potential in lipid research.
引用
收藏
页码:385 / 391
页数:7
相关论文
共 50 条
  • [31] Evolving Concepts of the Role of High-Density Lipoprotein in Protection from Atherosclerosis
    Farmer, John A.
    Liao, Joshua
    CURRENT ATHEROSCLEROSIS REPORTS, 2011, 13 (02) : 107 - 114
  • [32] Evolving Concepts of the Role of High-Density Lipoprotein in Protection from Atherosclerosis
    John A. Farmer
    Joshua Liao
    Current Atherosclerosis Reports, 2011, 13 : 107 - 114
  • [33] Atherosclerosis regression: Is low-density lipoprotein or high-density lipoprotein the answer?
    Nicholls S.J.
    Tuzcu E.M.
    Nissen S.E.
    Current Atherosclerosis Reports, 2007, 9 (4) : 266 - 273
  • [34] Association of High-Density Lipoprotein Subclasses with Chronic Kidney Disease Progression, Atherosclerosis, and Klotho
    Kanda, Eiichiro
    Al, Masumi
    Okazaki, Mitsuyo
    Yoshida, Masayuki
    Maeda, Yoshitaka
    PLOS ONE, 2016, 11 (11):
  • [35] Interaction between adipocytes and high-density lipoprotein:new insights into the mechanism of obesity-induced dyslipidemia and atherosclerosis
    Tianhua Zhang
    Jin Chen
    Xiaoyu Tang
    Qin Luo
    Danyan Xu
    Bilian Yu
    Lipids in Health and Disease, 18
  • [36] Interaction between adipocytes and high-density lipoprotein:new insights into the mechanism of obesity-induced dyslipidemia and atherosclerosis
    Zhang, Tianhua
    Chen, Jin
    Tang, Xiaoyu
    Luo, Qin
    Xu, Danyan
    Yu, Bilian
    LIPIDS IN HEALTH AND DISEASE, 2019, 18 (01)
  • [37] Safety and tolerability of simvastatin plus niacin in patients with coronary artery disease and low high-density lipoprotein cholesterol (The HDL Atherosclerosis Treatment Study)
    Zhao, XQ
    Morse, JS
    Dowdy, AA
    Heise, N
    DeAngelis, D
    Frohlich, J
    Chait, A
    Albers, JJ
    Brown, BG
    AMERICAN JOURNAL OF CARDIOLOGY, 2004, 93 (03): : 307 - 312
  • [38] Enhancement of high-density lipoprotein-associated protease inhibitor activity prevents atherosclerosis progression
    Mobilia, Maura
    Karakashian, Alexander
    Neupane, Khaga R.
    Hage, Olivia
    Whitus, Callie
    Carter, Abigail
    Voy, Clairity
    Johnson, Lance A.
    Graf, Gregory A.
    Gordon, Scott M.
    ATHEROSCLEROSIS, 2024, 396
  • [40] HIGH-DENSITY LIPOPROTEIN SUBFRACTIONS IN NORMOLIPIDEMIC PATIENTS WITH CORONARY ATHEROSCLEROSIS
    BROOK, JG
    AVIRAM, M
    VIENER, A
    SHILANSKY, E
    MARKIEWICZ, W
    CIRCULATION, 1982, 66 (05) : 923 - 926